Recalls & Warnings October 02, 2008 FDA Permits Incorrect Labeling on Generic Wellbutrin XL, But May Require Drug to be Tested The FDA has acknowledged inconsistencies in the labeling of Budeprion XL, a generic version of the antidepressant Wellbutrin XL, according to an October 2, 2008 article from Dow Jones News service
BPC-157 + TB500 (Thymosin Beta-4 Fragment) The BPC-157 + TB500 composite is a high-purity, research-grade peptide formulation engineered for advanced investigation into multimodal tissue repair and cellular signaling mechanisms
Growth Factors Uses growth factors to boost collagen production & reduce inflammation
We are currently transitioning to a new manufacturing partner based in the United States
Both boost energy, muscle, and recovery, but they work in very different ways